|
Our Mission
Genetic Immunity is an innovative biotech-nology company focusing on the development of nanomedicine based Therapeutic Vaccines against infection diseases and cancer.
Our Company
Genetic Immunity is a US/Hungarian biotech-nology company developing Nanomedicines for global unmet medical needs.
Based on our proprietary Nanomedicine Vaccine Technology, Nanomedicine Formulation and DermaPrep Targeted Delivery System, we are developing
Immune Therapies against
infectious diseases, cancer and allergies. more»
|
|
|
News Higlights
|
|
» Febuary 08, 2010
9-12 May 2010 3rd CLINAM Conference
» August 30, 2009
GI on the "sikertortenetem.hu"
|
Latest Press Release
|
|
» March 02, 2010
Genetic Immunity Presents DermaVir at DNA Vaccines 2010 Conference
( Click here to read the press release... ) |
|
Recent Projects
 » Clinical Trial: DermaVir Patch
Our first Phase II, placebo control-led, double blinded clinical trial is ongoing in Hamburg, Germany, and all patients are enrolled. more»
 » DermaPrep Medical Device
CE Mark was obtained for our DermaPrep transdermal delivery device ...
» Nanomedicine
Our Nanomedicine Antigen Composition (Nanomedicine) technology creates pathogen-like intelligent nanoparticles from antigens (e.g. pDNA, proteins,
peptides) to mimic a pathogen exposure. more»
|
